Skip to main content
Clinical Trials/NCT05340244
NCT05340244
Completed
Not Applicable

GE Cardiovascular Ultrasound Device Evaluation

GE Healthcare1 site in 1 country8 target enrollmentJune 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Echocardiography
Sponsor
GE Healthcare
Enrollment
8
Locations
1
Primary Endpoint
Number of De-identified Images
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of the study is to collect user feedback on the Vivid E95 ultrasound system and probes during clinical procedures on the device's intended population in order to optimize the device.

Detailed Description

The purpose of the study is to collect user feedback on the Vivid E95 ultrasound system and probes during clinical procedures on the device's intended population in order to optimize the device. The primary objective of this study is to collect user feedback and de-identified images from the Vivid E95 ultrasound system and probes in TTE and TEE exams in a clinical setting. User feedback will include workflow, performance, user preference, image quality, device features, and open-ended feedback. The safety objective of this study is to collect safety information, including type and number of adverse events and device issues. This is a pre-market, open label, prospective, non-randomized clinical research study conducted at one site in the United States. This study is not intended to support a comparative claim or test any hypotheses, such as superiority or non-inferiority. No clinical efficacy endpoints will be assessed.

Registry
clinicaltrials.gov
Start Date
June 1, 2022
End Date
July 26, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Has a clinical indication for a TEE and/or TTE procedure with an ultrasound device
  • Has a weight of at least 5kg
  • Are able and willing to comply with study procedures
  • If less than 7 years old, has a parent or legally authorized representative able and willing to provide written consent to participate
  • If 7-17 years old, are able and willing to provide written assent to participate AND have a parent or legally authorized representative able and willing to provide written consent to participate
  • If 18 years old or older, are able and willing to provide written consent to participate

Exclusion Criteria

  • Pregnant or suspected to be pregnant based on the opinion of a clinician investigator
  • Expected to be at increased risk due to study participation (e.g. due to sensitivities, relative or absolute contraindication to TEE), in the opinion of a clinician investigator
  • Previously participated in this study or are enrolled in another research study that could be expected to interfere with participation in study procedures
  • History of esophageal surgery or known vascular ring

Outcomes

Primary Outcomes

Number of De-identified Images

Time Frame: The total number of images collected will be reported. Multiple images are collected from each subject and the protocol does not require images to be collected at specific points in time. The device was used on each subject for about 15 minutes.

The primary objective of this study is to collect de-identified images from the investigational ultrasound system in TTE and TEE exams in a clinical setting.

Number of User Feedback Surveys

Time Frame: The total number of User Surveys will be reported. Surveys capture feedback from the device user across multiple subjects. The protocol did not require surveys be collected at specific timepoints. The device was used on each subject for about 15 minutes.

The primary objective of this study is to collect user feedback from the investigational ultrasound system in TTE and TEE exams in a clinical setting. User Surveys consist of Likert scales and qualitative feedback and this data will not follow a statistical analysis plan.

Study Sites (1)

Loading locations...

Similar Trials